Community First Bancshares Inc (NQ: CFBI )

10.08 USD UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Jan 20, 2021 Add to My Watchlist

Price and Volume

Volume	0
Open	10.08
Bid (Size)	10.08 (1)
Ask (Size)	10.40 (67)
Prev. Close	10.08
Today's Range	10.08 - 10.08
52wk Range	5.360 - 11.99
Shares Outstanding	7,538,250
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Community First Bancshares, Inc. Announces Expected Closing Date

January 18, 2021

Community First Bancshares, Inc. (the “Company”), the stock holding company of Newton Federal Bank (the “Bank”), announced today that it has received all required regulatory approvals for the...

Community First Bancshares, Inc. Announces Results of Special Meeting of Members

January 13, 2021

Community First Bancshares, Inc. (the “Company”), the stock holding company of Newton Federal Bank (the “Bank”), announced today that, at a special meeting held on January 12, 2021, the members of...

Performance

YTD	+3.81%	+3.81%
1 Month	+2.23%	+2.23%
3 Month	+30.91%	+30.91%
6 Month	+41.97%	+41.97%
1 Year	-15.79%	-15.79%

More News

Can-Fite Announces Publication of Namodenoson Liver Cancer Study in Peer Reviewed Journal—Cancers

January 08, 2021

Can-Fite Receives Israel Ministry of Health Approval to Conduct Research with Cannabinoids in Cancer, Inflammation and Obesity at the Company Discovery Labs

December 15, 2020

Can-Fite Reports on Progress With Its Namodenoson NASH Program

December 14, 2020

Can-Fite to Present at Benzinga Global Small Cap Conference on December 8, 2020

December 03, 2020

Can-Fite Reports Third Quarter 2020 Financial Results & Provides Clinical Update

November 30, 2020

Can-Fite’s Namodenoson Abstract Selected as ‘Best of The Liver Meeting’ in the NASH Category of the American Association of Liver Diseases (AASLD)

November 24, 2020

Community First Bancshares, Inc. Announces Commencement of Stock Offering

November 23, 2020

Can-Fite to Conduct Investor Call to Review Q3 Results and Provide Business Update on Monday, November 30, 2020 at 9:15 a.m. ET

November 23, 2020

Can-Fite Presented NASH Phase II Namodenoson Data at a Late Breaking Session of the American Association for the Study of Liver Diseases (AASLD) Conference

November 16, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.